We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mark Creager MD

Mark A Creager MD

Center Director, Dartmouth-Hitchcock Heart and Vascular Center, Lebanon, NH; President of the American Heart Assn 2015-2016,

Dr. Mark Creager is Professor of Cardiovascular Medicine at Harvard Medical School and Director of the Vascular Center at Brigham and Women’s Hospital in Boston.

After earning his medical degree at Temple University in Philadelphia, Dr. Creager completed his internal medicine residency and a peripheral vascular disease fellowship at University Hospital in Boston, and a cardiology fellowship at University Hospital and Boston City Hospital.

He is a member of the American College of Cardiology, the American Heart Association, and the Society for Vascular Medicine. He has received numerous awards and honors for his work, including the American Heart Association Council on Peripheral Vascular Disease Distinguished Achievement Award, the Vascular Disease Foundation President’s Award for Leadership, the Master of the Society for Vascular Medicine, and the Simon C. Fireman Scholar in Cardiovascular Medicine award at Brigham and Women’s Hospital.

Dr. Creager’s major research and clinical interest is in vascular medicine, specifically vascular regulatory mechanisms, atherosclerosis, and thrombosis. He is the author of more than 300 published contributions to the medical literature, including research papers on vascular function and clinical trials of peripheral artery disease, book chapters, and monographs on vascular disease.